<DOC>
	<DOCNO>NCT02965326</DOCNO>
	<brief_summary>The purpose study determine biological marker , association biological marker , best predict clinical response cystic fibrosis patient CFTR modulators .</brief_summary>
	<brief_title>Surrogate Markers Response New Therapies Cystic Fibrosis Patients</brief_title>
	<detailed_description>This study base upon hypothesis clinical response cystic fibrosis patient CFTR modulators correlate vitro response drug epithelial cell derive patient , assess CFTR-dependent Chloride secretion . Epithelial cell derive either nasal rectal epithelium , consist culture cell organoids . The drug test Ivacaftor , Lumacaftor/Ivacaftor , accord patient 's treatment . Results assay compare response treatment 6 12 month , assess clinical response vivo assay CFTR function .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>Cystic fibrosis patient treat CFTR modulators ( Ivacaftor association IvacaftorLumacaftor ) Cystic fibrosis patient non treat CFTR modulators Patients cystic fibrosis diagnosis suspect , exclude physiological genetic investigation pregnant lactate woman contraindication nasal swab contraindication rectal biopsy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>